Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2026-01-03 @ 5:29 PM
Study NCT ID:
NCT06532058
Status:
RECRUITING
Last Update Posted:
2024-08-01
First Post:
2024-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia
Sponsor:
Changzhou Qianhong Bio-pharma Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
QH-RD107-02-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None